JESSICA JOYCE: Open Payments
NPI 1992168850 · GLEN ALLEN, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,266 in 110 payments from 14 companies in 2025. Trend: 2023 $1,748 · 2024 $1,820 · 2025 $2,266
Food & beverage: $2,067Education: $199
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 56 | $1,004 |
| ABBVIE INC. | 17 | $270 |
| Novartis Pharmaceuticals Corporation | 9 | $208 |
| Organon LLC | 4 | $195 |
| UCB, Inc. | 4 | $111 |
| Regeneron Healthcare Solutions, Inc. | 4 | $102 |
| Arcutis Biotherapeutics, Inc. | 4 | $79 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $76 |
| GENZYME CORPORATION | 3 | $75 |
| Incyte Corporation | 2 | $55 |
Products named: TREMFYA, SKYRIZI, VTAMA, DUPIXENT, Bimzelx, COSENTYX, Zoryve, OPZELURA.
Industry payments across VA — which companies pay providers there.
